NEU 3.42% $20.54 neuren pharmaceuticals limited

HI GC - great post as usual. Although after reading it I did...

  1. 29 Posts.
    lightbulb Created with Sketch. 6
    HI GC - great post as usual. Although after reading it I did have a look around myself - and noticed that Taysha has applied for clinical trials in the UK -

    "Taysha has submitted a Clinical Trial Application to the UK regulator, the MHRA for a clinical trial in children. No information has been shared regarding age group at this time. "

    Now from my perspective - having to wait several years before Daybue will possibly arrive in the UK - this trial is very tempting to help my daughter and I would assume the same for other parents of Rett children in the UK - so albeit a small market it could be that Daybue gets here too late, obviously depending on how speedily the gene therapy trials can complete.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.